Document is current

Article History

Received: 5 December 2023

Accepted: 31 January 2024

First Online: 14 February 2024

Declarations

:

: The study was approved by the Institutional Review Board of the Medical Faculty of the Technical University Dresden (BO-EK-146032023) and the State Chamber of Physicians of Saxony (EK-BR-46/23 − 1). Informed consent will be obtained from all subjects. If consent is declined, an anonymized process data record will be transmitted. Informed consent materials can be requested from the authors. The study is carried out in accordance with the WMA Declaration of Helsinki. We adhere to a data protection concept specifically developed for the study. Protocol modifications will be published in the German clinical trials register.

: Not applicable.

: Helene Hense, Josephine Mathiebe, Sven Helfer, Rick Glaubitz, Cahit Birdir and Gabriele Müller declare no competing interests. Unrelated to this study, Mario Rüdiger reports institutional grants for investigator-initiated research from the German GBA, the BMG, BMBF, EU and DFG. He received a personal fee for the following activities: advisor on the advisory board (companies), organization of training events (Chiesi, AstraZeneca), speaker (Chiesi). MR is active on the board of the German Society for Perinatal Medicine, on the board of the German Foundation for Sick Newborns and on the Neonatal Task Force of the International Liason Committee of Resuscitation (ILCOR) and the European Resuscitation Council (ERC). Unrelated to this study, Jochen Schmitt reports institutional grants for investigator-initiated research from the German GBA, the BMG, BMBF, Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He also participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. JS is a member of the Expert Council for Health and Care at the Federal Ministry of Health and a member of the Government Commission for a Modern and Needs-Bases Hospital Care.